Hannover Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (24)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

    HIV Medicine, Vol. 23, Núm. 6, pp. 639-649

  2. Motherhood and Treatment Outcome in Female Patients with Compulsive Buying–Shopping Disorder

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 12

2021

  1. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2

    Wellcome Open Research, Vol. 6

2019

  1. Spanish validation of the pathological buying screener in patients with eating disorder and gambling disorder

    Journal of Behavioral Addictions, Vol. 8, Núm. 1, pp. 123-134

  2. Underlying mechanism of the comorbid presence of buying disorder with gambling disorder: A pathways analysis

    Journal of Gambling Studies, Vol. 35, Núm. 1, pp. 261-273

  3. Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Journal of Hepatology, Vol. 71, Núm. 2, pp. 397-408

2016

  1. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

2015

  1. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    HIV Medicine, Vol. 16, Núm. 9, pp. 533-543

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  3. Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 2, pp. 1282-1291

2014

  1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Infection, Vol. 42, Núm. 4, pp. 757-762

  2. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study

    BMC Nephrology, Vol. 15, Núm. 1

  3. Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

    PLoS ONE, Vol. 8, Núm. 5

2012

  1. Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients

    AIDS, Vol. 26, Núm. 15, pp. 1917-1926

  2. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA study

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy

    Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752

  2. The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference

    Journal of Viral Hepatitis, Vol. 18, Núm. SUPPL. 1, pp. 1-16

2010

  1. Dialysis and renal transplantation in HIV-infected patients: A European survey

    Journal of Acquired Immune Deficiency Syndromes, Vol. 55, Núm. 5, pp. 582-589